Fisher Wallace Laboratories

Medical Devices for Mood and Sleep

Print
Claim My Business View on StartEngine
Amount Raised: $717,211
Security Type
Non-Voting Equity
Categories
General, Technology
Min Investment
$493
Location
BROOKLYN, NY
Offering Date
October 07, 2019
Expected Close Date
February 20, 2023
Target Raise
$10.00K-$1.84M
No. Investors
376
Security Price
$8.81
Deal Notes

Security Name: Class B Non-Voting Stock

$2.50 per share

Valuation
$81,567,588
Number of Employees
12
Cash
$1,929,380
Revenue
$4,230,290
Short Term Debt
$471,468
Cost of Goods
$623,703
Long Term Debt
$576,525
Net Income
$3,262,291

Company Description

Fisher Wallace manufactures and markets wearable medical devices for the treatment of depression, anxiety and insomnia.

Use of Proceeds

StartEngine Platform Fees: 3.5%, 

Marketing: 50.5%, 

Research & Development: 46.0

Perks

$1500+ | 42% discount on the purchase of a Fisher Wallace device
$5,000+ | Above + 2% bonus shares
$10,000+ | Above + 3% bonus shares
$20,000+ | Above + 5% bonus shares

Key Deal Facts

An FDA-Cleared, clinically validated solution for depression, anxiety and insomnia with over 50,000 patients and 10,000 prescribers in the United States
$4.7 Million net revenue in 2018 with total lifetime revenue of $23.3 Million
Named an INC 5000 fastest growing company with OTC approval in Europe, Canada, Mexico and Brazil, and recently obtained Medicaid approval in Maine (MaineCare)

Use of Proceeds

StartEngine Platform Fees: 3.5%, 

Marketing: 50.5%, 

Research & Development: 46.0

Perks

$1500+ | 42% discount on the purchase of a Fisher Wallace device
$5,000+ | Above + 2% bonus shares
$10,000+ | Above + 3% bonus shares
$20,000+ | Above + 5% bonus shares

Management Team / Advisory Board Bios

Kelly Roman
Co-Founder & CEO & Director
For the past decade, Kelly Roman has helped lead the fields of neuromodulation product development, regulatory affairs, healthcare marketing and clinical trial strategy. Prior to co-founding Fisher Wallace, Kelly graduated from Harvard and served as an award-winning executive in the digital advertising and SaaS industries. He currently serves on the boards of two charter high schools in New York City.

Charles Fisher
Co-Founder & Chairman & Director
Charles “Chip” Fisher grew up in the electronics business before helping pioneer the neuromodulation industry - his father, Avery Fisher, founded Fisher Radio (later named Fisher Electronics). After graduating from Harvard and serving as a sales executive at IBM, Chip acquired the original intellectual property to the Fisher Wallace Stimulator and is the company’s largest shareholder - and recent TEDx contributor.

Security Description

Non-voting stock is stock that provides the shareholder very little or no vote on corporate matters.

Research Reports

No reports have been submitted

Become a Reporter

0 Comments